Protalix Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.33

-0.02 (-0.85%)

As of Jul 4, 2:07 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +1,239.5% upside

Low Target $17.92

Average Target $31.21

High Target $31.70

Current Price $2.33

Current
$2.33

Target
$31.21

$17.92 $31.21 avg $31.70

Scenario Analysis

Bear Case

$17.92

669.1%

Low target

Base Case

$31.21

+1,239.5%

Avg target

Bull Case

$31.70

+1,260.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.19

-27.0% from high

52-Week Low

$1.36

+71.3% from low

Target vs 52W High

$31.21

+878.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%